Related Experiment Video
Updated: Jan 13, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
The mitochondrial protective mechanisms mediated by SGLT2i: from molecular basis to clinical implications
Jianing Chen1, Fengqi Wan2, Kaiyue Wu3
1Children's Functional Examination Department, The Second Hospital of Lanzhou University, Lanzhou, China.
Abstract:
SGLT2 inhibitors(SGLT2i) inhibit glucose reabsorption in renal proximal tubules, promote urinary glucose excretion, and lower blood glucose. They also protect cardiovascular, renal, and nervous systems, though mechanisms remain unclear.Mitochondria are key organelles for energy metabolism, redox balance, and calcium regulation, playing a critical role in chronic disease pathogenesis and progression.SGLT2i improve mitochondrial function by enhancing quality control, modulating energy metabolism, strengthening antioxidant defenses, and maintaining calcium homeostasis.These mitochondria-centered mechanisms may underlie SGLT2i protection of cardiovascular, renal, and neurological systems. This review summarizes these effects and discusses therapeutic implications.
Insights
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower blood glucose and protect organs. These drugs improve mitochondrial function, which may explain their protective effects on the cardiovascular, renal, and nervous systems.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower blood glucose by inhibiting renal glucose reabsorption.
- SGLT2i demonstrate protective effects on cardiovascular, renal, and nervous systems, but the underlying mechanisms are not fully understood.
- Mitochondria are crucial for cellular energy, redox balance, and calcium regulation, and are implicated in chronic disease progression.
Purpose of the Study:
- To review the mitochondria-centered mechanisms underlying the protective effects of SGLT2 inhibitors.
- To explore how SGLT2i modulate mitochondrial function and its impact on organ protection.
- To discuss the therapeutic implications of these findings.
Main Methods:
- Literature review focusing on studies investigating SGLT2 inhibitors and mitochondrial function.
- Analysis of research on the role of mitochondria in cardiovascular, renal, and neurological diseases.
- Synthesis of evidence linking SGLT2i-induced mitochondrial improvements to organ protection.
Main Results:
- SGLT2i enhance mitochondrial quality control mechanisms.
- SGLT2i modulate mitochondrial energy metabolism and strengthen antioxidant defenses.
- SGLT2i contribute to maintaining mitochondrial calcium homeostasis.
Conclusions:
- Mitochondrial improvements, including enhanced quality control, modulated metabolism, and preserved calcium homeostasis, are key mechanisms for SGLT2i organ protection.
- Targeting mitochondrial function represents a promising therapeutic strategy for chronic diseases.
- Further research into these mitochondria-centered effects could optimize SGLT2i utilization and uncover new therapeutic avenues.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Secondary Active Transport
Secondary Active Transport
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
Glucose Absorption Into the Small Intestine
